Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia

Open access

Abstract

BACKGROUND: Glucagon like peptide-1 (GLP-1) stimulates insulin secretion from the pancreas but also has extra-pancreatic effects. GLP-1 may stimulate glucose uptake in cultured muscle cells but the mechanism is not clearly defined. Furthermore, while the pancreatic effects of GLP-1 are glucose-dependent, the glucose-dependency of its extra-pancreatic effects has not been examined. METHODS: Skeletal muscle satellite cells isolated from young (22.5 ± 0.97 yr), lean (BMI 22.5 ± 0.6 kg/m(2)), healthy males were differentiated in media containing either 22.5 mM (high) or 5 mM (normal) glucose for 7 days in the absence or presence of insulin and/or various GLP-1 concentrations. Myocellular effects of GLP-1, insulin and glucose were assessed by western-blot, glucose uptake and glycogen synthesis. RESULTS: We firstly show that the GLP-1 receptor protein is expressed in differentiated human muscle satellite cells (myocytes). Secondly, we show that in 5 mM glucose media, exposure of myocytes to GLP-1 results in a dose dependent increase in glucose uptake, GLUT4 amount and subsequently glycogen synthesis in a PI3K dependent manner, independent of the insulin signaling cascade. Importantly, we provide evidence that differentiation of human satellite cells in hyperglycemic (22.5 mM glucose) conditions increases GLUT1 expression, and renders the cells insulin resistant and interestingly GLP-1 resistant in terms of glucose uptake and glycogen synthesis. Hyperglycemic conditions did not affect the ability of insulin to phosphorylate downstream targets, PKB or GSK3. Interestingly we show that at 5 mM glucose, GLP-1 increases GLUT4 protein levels and that this effect is abolished by hyperglycemia. CONCLUSIONS: GLP-1 increases glucose uptake and glycogen synthesis into fully-differentiated human satellite cells in a PI3-K dependent mechanism potentially through increased GLUT4 protein levels. The latter occurs independently of the insulin signaling pathway. Attenuation of both GLP-1 and insulin-induced glucose metabolism by hyperglycemia is likely to occur downstream of PI3K.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0044284

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 GLP-1 receptor protein expression in human skeletal muscle tissue and human myocytes. (A) Protein lysate (20 µg) from either INS-1 cells, human skeletal muscle tissue or human myocytes (fully differentiated satellite cells) were immunoblotted to assess the protein expression of the GLP-1 receptor (GLP-1R). A band was visualized at approximately 53 kDa in INS-1 cells corresponding to the GLP-1R. This band was also detected in both human muscle tissue and myocytes. The GLP-1R expression in myocytes was assessed when cells were differentiated in 22.5 mM (lane 1) and 5 mM (lane 2) glucose. (B) Satellite cell protein was collected when cells fully confluent (Day −1), after alignment (day 0) and after 2, 4 6 and 8 days of differentiation in either high (22.5 mM) or normal glucose (5 mM) media. Total protein lysate was immunoblotted to assess the expression of GLP-1 receptor and Myosin heavy chain 2a (MyHC2a). Equal protein was ascertained by immunoblotting with an antibody against β-tubulin. (C) Quantification of GLP-1 receptor during and differentiation (n = 4), bars represent fully confluent cells (day −1), aligned cells (day 0) and cells after 2, 4, 6 and 8 days of differentiation in either high (open bars) or normal glucose (black bars) media. GLP-1 receptor expression expressed normalized to total protein and expressed as arbitrary units. Significant changes from day −1 and day 0 are indicated by *** (P<0.0005).
Figure 1 GLP-1 receptor protein expression in human skeletal muscle tissue and human myocytes. (A) Protein lysate (20 µg) from either INS-1 cells, human skeletal muscle tissue or human myocytes (fully differentiated satellite cells) were immunoblotted to assess the protein expression of the GLP-1 receptor (GLP-1R). A band was visualized at approximately 53 kDa in INS-1 cells corresponding to the GLP-1R. This band was also detected in both human muscle tissue and myocytes. The GLP-1R expression in myocytes was assessed when cells were differentiated in 22.5 mM (lane 1) and 5 mM (lane 2) glucose. (B) Satellite cell protein was collected when cells fully confluent (Day −1), after alignment (day 0) and after 2, 4 6 and 8 days of differentiation in either high (22.5 mM) or normal glucose (5 mM) media. Total protein lysate was immunoblotted to assess the expression of GLP-1 receptor and Myosin heavy chain 2a (MyHC2a). Equal protein was ascertained by immunoblotting with an antibody against β-tubulin. (C) Quantification of GLP-1 receptor during and differentiation (n = 4), bars represent fully confluent cells (day −1), aligned cells (day 0) and cells after 2, 4, 6 and 8 days of differentiation in either high (open bars) or normal glucose (black bars) media. GLP-1 receptor expression expressed normalized to total protein and expressed as arbitrary units. Significant changes from day −1 and day 0 are indicated by *** (P<0.0005).CC BY · PubMed Central
Figure 2 Effect of GLP-1 treatment on glucose uptake into myocytes cultured in high or normal glucose media. Satellite cells were isolated from lean, healthy males (n = 6), differentiated in either high glucose (22 mM, open bars) containing media or normal glucose (5 mM, black bars) containing media for seven days. A) Myocytes were treated with either 100 nM insulin or GLP-1 at indicated concentrations for 30 minutes before assessing 2-deoxyglucose uptake. B) Glucose uptake was expressed as a percent change from basal levels for either high (open bars) or normal (black bars) glucose conditions. C) Myocytes treated with GLP-1 concentrations only in both glucose conditions were subjected to a two-way ANOVA. ** denotes a significant change (P<0.005) from basal levels. * denotes a significant difference (P<0.05) between glucose conditions.
Figure 2 Effect of GLP-1 treatment on glucose uptake into myocytes cultured in high or normal glucose media. Satellite cells were isolated from lean, healthy males (n = 6), differentiated in either high glucose (22 mM, open bars) containing media or normal glucose (5 mM, black bars) containing media for seven days. A) Myocytes were treated with either 100 nM insulin or GLP-1 at indicated concentrations for 30 minutes before assessing 2-deoxyglucose uptake. B) Glucose uptake was expressed as a percent change from basal levels for either high (open bars) or normal (black bars) glucose conditions. C) Myocytes treated with GLP-1 concentrations only in both glucose conditions were subjected to a two-way ANOVA. ** denotes a significant change (P<0.005) from basal levels. * denotes a significant difference (P<0.05) between glucose conditions.CC BY · PubMed Central
Figure 3 Effect of GLP-1 treatment on the insulin signaling cascade in myocytes cultured in high or normal glucose media. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM) or normal glucose (5 mM) media for seven days. Myocytes were treated with either 100 nM insulin or GLP-1 at indicated concentrations for 30 minutes before A) immunoblotting to assess the phosphorylation status of PKB/Akt, GSK3 and ERK1/2 and the total protein abundance of PKB/Akt and GLP-1R. Equal loading was ascertained by immunoblotting with an antibody against β-tubulin. Effect of high (open bars) and normal (black bars) glucose on phosphorylation of PKB Ser473 (B), PKB Thr308 (C), GSK3 (D) and ERK (E), and the total protein amount of GLP-1R (F) induced by insulin and GLP-1 was quantified (n = 6), normalized to total protein and expressed as arbitrary units. Significant changes from basal levels are indicated by * (P<0.05), ** (P<0.001), and *** (P<0.0001). Significant differences between normal and high glucose in the basal state is indicted by ∼ (P<0.05).
Figure 3 Effect of GLP-1 treatment on the insulin signaling cascade in myocytes cultured in high or normal glucose media. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM) or normal glucose (5 mM) media for seven days. Myocytes were treated with either 100 nM insulin or GLP-1 at indicated concentrations for 30 minutes before A) immunoblotting to assess the phosphorylation status of PKB/Akt, GSK3 and ERK1/2 and the total protein abundance of PKB/Akt and GLP-1R. Equal loading was ascertained by immunoblotting with an antibody against β-tubulin. Effect of high (open bars) and normal (black bars) glucose on phosphorylation of PKB Ser473 (B), PKB Thr308 (C), GSK3 (D) and ERK (E), and the total protein amount of GLP-1R (F) induced by insulin and GLP-1 was quantified (n = 6), normalized to total protein and expressed as arbitrary units. Significant changes from basal levels are indicated by * (P<0.05), ** (P<0.001), and *** (P<0.0001). Significant differences between normal and high glucose in the basal state is indicted by ∼ (P<0.05).CC BY · PubMed Central
Figure 4 Effect of GLP-1 and/or insulin on glucose uptake and GLUT4 protein. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM, open bars) or normal glucose (5 mM, black bars) media for seven days. Myocytes were treated with either 100 nM insulin and/or 100 nM GLP-1 for 30 minutes before either (A) assessing 2-deoxyglucose uptake or (B) immunoblotting to assess phosphorylation status of PKB/Akt and total protein amount of PKB/Akt or (C) immunoblotting to assess the protein level of GLUT4. The effect of high (open bars) and normal (black bars) glucose on GLUT4 protein level was quantified ((D); n = 6), normalized to total protein and expressed as arbitrary units. Significant changes from basal levels are indicated by * (P<0.05), ** (P<0.001), and *** (P<0.0001). (E) The effect of high glucose on GLUT1 mRNA expression in the basal state was measured by qPCR (n = 4). The significant effect of high (open bars) glucose on GLUT1 expression relative to normal (black bars) glucose is indicated by * (P<0.05).
Figure 4 Effect of GLP-1 and/or insulin on glucose uptake and GLUT4 protein. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM, open bars) or normal glucose (5 mM, black bars) media for seven days. Myocytes were treated with either 100 nM insulin and/or 100 nM GLP-1 for 30 minutes before either (A) assessing 2-deoxyglucose uptake or (B) immunoblotting to assess phosphorylation status of PKB/Akt and total protein amount of PKB/Akt or (C) immunoblotting to assess the protein level of GLUT4. The effect of high (open bars) and normal (black bars) glucose on GLUT4 protein level was quantified ((D); n = 6), normalized to total protein and expressed as arbitrary units. Significant changes from basal levels are indicated by * (P<0.05), ** (P<0.001), and *** (P<0.0001). (E) The effect of high glucose on GLUT1 mRNA expression in the basal state was measured by qPCR (n = 4). The significant effect of high (open bars) glucose on GLUT1 expression relative to normal (black bars) glucose is indicated by * (P<0.05).CC BY · PubMed Central
Figure 5 Effect of GLP-1 treatment on glycogen synthesis in myocytes cultured in high or normal glucose media. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM, open bars) or normal glucose (5 mM, black bars) media for seven days. Myocytes were treated with either 100 nM insulin and/or 100 nM GLP-1 for 30 minutes before assessing glycogen synthesis (by measuring incorporation of [14C]-glucose in to glycogen). (A) Shows absolute rates of glycogen synthesis in the basal level (n = 6, in triplicate); (B) indicates fold changes from basal levels for each glucose condition. Significant changes from basal levels are indicated by * (P<0.05), and ** (P<0.001).
Figure 5 Effect of GLP-1 treatment on glycogen synthesis in myocytes cultured in high or normal glucose media. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM, open bars) or normal glucose (5 mM, black bars) media for seven days. Myocytes were treated with either 100 nM insulin and/or 100 nM GLP-1 for 30 minutes before assessing glycogen synthesis (by measuring incorporation of [14C]-glucose in to glycogen). (A) Shows absolute rates of glycogen synthesis in the basal level (n = 6, in triplicate); (B) indicates fold changes from basal levels for each glucose condition. Significant changes from basal levels are indicated by * (P<0.05), and ** (P<0.001).CC BY · PubMed Central
Figure 6 The effect of GLP-1 on glucose uptake in myocytes cultured in normal glucose media is PI3K-dependent. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM, open bars) or normal glucose (5 mM, black bars) media for seven days. Myocytes were treated with 100 nM wortmannin (40 minutes) in the absence or presence of either 100 nM insulin or 100 nM GLP-1 for the penultimate 30 minutes before assessing 2-deoxyglucose uptake in to myocytes (A) cultured in high glucose (22 mM) or (B) normal glucose (5 mM) media. (C) Lysates were immunoblotted for phosphorylation status of PKB/Akt and PKCζ/λ and total protein amount of PKB/Akt under the same conditions. Immunoblots were quantified (n = 6), normalized to total protein and expressed as arbitrary units (D and E). (F) Total protein amount of GLUT4 was assessed by immunoblot and quantified (n = 5). Significant changes from basal levels are indicated by * (P<0.05), ** (P<0.001), and *** (P<0.0001). A # denotes a significant change (P<0.05) from insulin treatment and a $ denotes a significant change (P<0.05) from GLP-1 treatment.
Figure 6 The effect of GLP-1 on glucose uptake in myocytes cultured in normal glucose media is PI3K-dependent. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM, open bars) or normal glucose (5 mM, black bars) media for seven days. Myocytes were treated with 100 nM wortmannin (40 minutes) in the absence or presence of either 100 nM insulin or 100 nM GLP-1 for the penultimate 30 minutes before assessing 2-deoxyglucose uptake in to myocytes (A) cultured in high glucose (22 mM) or (B) normal glucose (5 mM) media. (C) Lysates were immunoblotted for phosphorylation status of PKB/Akt and PKCζ/λ and total protein amount of PKB/Akt under the same conditions. Immunoblots were quantified (n = 6), normalized to total protein and expressed as arbitrary units (D and E). (F) Total protein amount of GLUT4 was assessed by immunoblot and quantified (n = 5). Significant changes from basal levels are indicated by * (P<0.05), ** (P<0.001), and *** (P<0.0001). A # denotes a significant change (P<0.05) from insulin treatment and a $ denotes a significant change (P<0.05) from GLP-1 treatment.CC BY · PubMed Central
Figure 7 Schematic diagram illustrating the effects of GLP-1 and insulin on skeletal muscle glucose metabolism under normal glucose conditions and during hyperglycemia. A) GLP-1 effects: Under normal glucose conditions, we propose that GLP-1 signals through its receptor promoting PI3K activation and an increased level of GLUT4 protein (potentially through an increased synthesis of GLUT4 storage vesicles) in the cytoplasm resulting in increased glucose uptake into the cell. GLP-1 stimulates glucose uptake independently of PKB phosphorylation and promotes glucose storage independently of GSK3 phosphorylation. GLP-1 also has no effect on phosphorylation of atypical PKC's. B) Hyperglycemia effects: Hyperglycemia had no effect on insulin-stimulated PKB or GSK3 phosphorylation but attenuates insulin-mediated glucose uptake and subsequently glycogen synthesis. Hyperglycemia is unlikely to suppress GLP-1-induced PI3K activity; however it significantly suppresses GLP-1 induced increases in GLUT4 protein levels. Following from this hyperglycemia blocks GLP-1-induced glucose uptake into the cells and resultant glycogen synthesis.
Figure 7 Schematic diagram illustrating the effects of GLP-1 and insulin on skeletal muscle glucose metabolism under normal glucose conditions and during hyperglycemia. A) GLP-1 effects: Under normal glucose conditions, we propose that GLP-1 signals through its receptor promoting PI3K activation and an increased level of GLUT4 protein (potentially through an increased synthesis of GLUT4 storage vesicles) in the cytoplasm resulting in increased glucose uptake into the cell. GLP-1 stimulates glucose uptake independently of PKB phosphorylation and promotes glucose storage independently of GSK3 phosphorylation. GLP-1 also has no effect on phosphorylation of atypical PKC's. B) Hyperglycemia effects: Hyperglycemia had no effect on insulin-stimulated PKB or GSK3 phosphorylation but attenuates insulin-mediated glucose uptake and subsequently glycogen synthesis. Hyperglycemia is unlikely to suppress GLP-1-induced PI3K activity; however it significantly suppresses GLP-1 induced increases in GLUT4 protein levels. Following from this hyperglycemia blocks GLP-1-induced glucose uptake into the cells and resultant glycogen synthesis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 80

Metadata

Authors
Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J.
Affiliations
University of Copenhagen (DK)
Corresponding author
Green, Charlotte J.
Venue
PLoS ONE
Published
2012-08-28
Volume
7
Issue
8
Pages
e44284
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1984706454
Cited by
80
References
43
Citations by year
2026: 5 · 2025: 10 · 2024: 7 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 7 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 8 · 2014: 3 · 2013: 7
FWCI
2.31
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
Funders
  • National Research Foundation
  • European Foundation for the Study of Diabetes
  • Danmarks Grundforskningsfond (# 02-512-55)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
glucagon-like peptide-1, hyperglycemia, satellite cells, skeletal muscle fibers, glucose uptake, GLUT4, GLUT1, glycogen synthesis, PI3K signaling, insulin resistance, insulin signaling, GLP-1 receptor, glucose metabolism
MeSH terms
Glucagon-Like Peptide-1 Receptor, Cell Differentiation, Cells, Cultured, Glucose, Glycogen, Humans, Hyperglycemia, Insulin, Male, Signal Transduction, Receptors, Glucagon, Satellite Cells, Skeletal Muscle, Cell Proliferation, Glucagon-Like Peptide 1, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia. https://app.cochat.ai/papers/10.1371/journal.pone.0044284
The paper
Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J. (2012). Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia. PLoS ONE. https://doi.org/10.1371/journal.pone.0044284

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.